<code id='BE576762D8'></code><style id='BE576762D8'></style>
    • <acronym id='BE576762D8'></acronym>
      <center id='BE576762D8'><center id='BE576762D8'><tfoot id='BE576762D8'></tfoot></center><abbr id='BE576762D8'><dir id='BE576762D8'><tfoot id='BE576762D8'></tfoot><noframes id='BE576762D8'>

    • <optgroup id='BE576762D8'><strike id='BE576762D8'><sup id='BE576762D8'></sup></strike><code id='BE576762D8'></code></optgroup>
        1. <b id='BE576762D8'><label id='BE576762D8'><select id='BE576762D8'><dt id='BE576762D8'><span id='BE576762D8'></span></dt></select></label></b><u id='BE576762D8'></u>
          <i id='BE576762D8'><strike id='BE576762D8'><tt id='BE576762D8'><pre id='BE576762D8'></pre></tt></strike></i>

          hotspot

          hotspot

          author:comprehensive    Page View:942
          After a drawn-out lobbying fight, ARPA-H chose its headquarters: a hub and spokes model, with three central locations in Boston, Texas, and D.C. David L. Ryan/Boston Globe

          WASHINGTON — Cities and states have been clamoring to play host to the Advanced Research Projects Agency for Health since before the agency existed — before, in fact, anyone truly knew what ARPA-H was.

          But the lobbying campaign from universities, business leaders, members of Congress, and big-city mayors is finally over.

          advertisement

          The end came not with a dramatic reveal or a formal ribbon-cutting, but with a largely bureaucratic and anticlimactic announcement that the Biden administration plans to share the wealth. ARPA-H will be housed in a hub-and-spoke model across three major metro areas: The D.C. suburbs; Cambridge, Mass.; and Dallas. Additional “spokes,” the agency announced Tuesday, will be spread across the country at 10 sites spanning from Florida to Alaska.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more
          Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable
          Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

          CTscansshowedthatthepatientinitiallyrespondedtolorlatinib(left).Buteightmonthslater,themetastaticliv

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          STAT Wunderkinds: Ruey Hu's digital tools for parsing research

          HugraduatingfromJohnsHopkinsandbeinginductedintotheDeltaOmegaPublicHealthHonorSocietyin2017.Courtesy